TAKEDA MANUFACTURING AUSTRIA AG
ItalyAll drugs from this manufacturer
-
It is used for the treatment and prevention of bleeding in patients of all ages with hemophilia A, a hereditary disorder caused by a deficiency of factor VIII.
Dosage form: solution for injection, powder and solvent
Active substance Dosage octocog alfa - ATC: B02BD02
-
ADZYNMA is used to replenish levels of the ADAMTS13 enzyme, which is absent in people with congenital thrombotic thrombocytopenic purpura (cTTP). This helps to reduce the likelihood of dangerous blood clot formation and to prevent low platelet levels in the blood.
Dosage form: solution for injection, powder and solvent
Active substance Dosage radamts13 - ATC: B01AD13
-
It is used to treat and prevent thrombotic and hemorrhagic skin lesions (purpura fulminans) in patients with severe congenital protein C deficiency. It is also used to treat a rare complication caused by certain anticoagulant drugs (coumarins) and to prevent thrombosis in patients with severe protein C deficiency in specific situations, such as before surgery or at the start of coumarin therapy.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human protein c - ATC: B01AD12
-
It is used to increase C1 esterase inhibitor levels in the blood to prevent or stop swelling attacks (angioedema). It can be used for routine prevention or before medical and dental procedures in adults, adolescents, and children aged 6 years and older. In children between 2 and 11 years of age, it is indicated for the treatment of attacks and prevention before medical procedures.
Dosage form: solution for injection, powder and solvent
Active substance Dosage c1-inhibitor, plasma derived - ATC: B06AC01
-
It is used to treat patients with antibody deficiency (both congenital and secondary) to prevent infections, and to treat certain inflammatory disorders such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, multifocal motor neuropathy, and CIDP.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin - ATC: J06BA02
-
This medicine is used for two main purposes: as replacement therapy for patients who do not have enough antibodies in their blood (to prevent recurrent infections) and for the treatment of certain inflammatory or autoimmune diseases, such as Guillain-Barré syndrome, Kawasaki disease, or primary immune thrombocytopenia.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin - ATC: J06BA02